Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has filed four products for Abbreviated New Drug Applications and received nine approvals from the USFDA in the first quarter this fiscal. The company has now 320 ANDAs approval out of a total of 453 products filed with USFDA, and ANDAs approvals for remaining 133 products are still awaited. On a consolidated basis, the company now has 791 patent filings with 503 granted patents.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.